Teva to Buy Leading Mexican Pharma Firm

Published on: 

October 02, 2015.

Teva (Petah Tikva, Israel) has entered into an agreement to acquire Mexican pharma company Representaciones e Investigaciones Médicas (Rimsa) for $2.3 billion, according to

Rimsa, which had a 2014 revenue of $227 million, has a portfolio of specialty products, including fixed-dose combination products. The company has a 45-year history as one of Mexico's companies; Mexico is the second largest healthcare market in Latin America.


Teva expects to close the transactions by Q1 2016.